Anixa Biosciences (ANIX) News Today $3.01 +0.06 (+2.03%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$3.00 -0.01 (-0.33%) As of 08/28/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceAugust 25, 2025 | prnewswire.comD. Boral Capital Reiterates Buy Rating for Anixa Biosciences (NASDAQ:ANIX)August 21, 2025 | marketbeat.comAnixa receives notice of allowance in China for cancer vaccine technology patentAugust 20, 2025 | msn.comAnixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine TechnologyAugust 20, 2025 | prnewswire.comAnixa Biosciences, Inc.: Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical TrialAugust 18, 2025 | finanznachrichten.deAnixa Biosciences treats second patient in fourth ovarian cancer trial cohortAugust 18, 2025 | msn.comAnixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical TrialAugust 18, 2025 | prnewswire.comAnixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T TechnologyAugust 12, 2025 | prnewswire.comAnixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer ConferenceAugust 8, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Receives "Buy" Rating from D. Boral CapitalAugust 6, 2025 | marketbeat.comAnixa Biosciences Inc (NASDAQ:ANIX) Director Buys $30,800.00 in StockAugust 5, 2025 | marketbeat.comAnixa Biosciences Inc (NASDAQ:ANIX) Director Acquires $30,800.00 in StockAugust 5, 2025 | insidertrades.comAnixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine TrialAugust 4, 2025 | prnewswire.comInsider Buying: Anixa Biosciences Inc (NASDAQ:ANIX) CEO Buys 5,000 Shares of StockAugust 1, 2025 | marketbeat.comAnixa Biosciences Inc (NASDAQ:ANIX) CEO Buys $15,800.00 in StockAugust 1, 2025 | insidertrades.comAnixa Biosciences stock rises after securing Canadian patent allowanceJuly 30, 2025 | investing.comAnixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine TechnologyJuly 30, 2025 | prnewswire.comAnixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040sJuly 24, 2025 | prnewswire.comArnold M. Baskies Purchases 5,000 Shares of ANIXA BIOSCIENCES INC (NASDAQ:ANIX) StockJuly 22, 2025 | insidertrades.comAnixa Biosciences Inc (NASDAQ:ANIX) Director Purchases $16,950.00 in StockJuly 21, 2025 | marketbeat.comAnixa Biosciences Inc (NASDAQ:ANIX) Director Acquires $31,400.00 in StockJuly 16, 2025 | insidertrades.comAnixa Biosciences: Oncology Platform With Asymmetric UpsideJuly 15, 2025 | seekingalpha.comInsider Buying: Anixa Biosciences Inc (NASDAQ:ANIX) Director Acquires 10,000 Shares of StockJuly 15, 2025 | marketbeat.comAnixa Biosciences Inc (NASDAQ:ANIX) CEO Amit Kumar Acquires 5,000 SharesJuly 15, 2025 | insidertrades.comAnixa Biosciences Inc (NASDAQ:ANIX) CEO Amit Kumar Purchases 5,000 SharesJuly 14, 2025 | marketbeat.comA New Vaccine Could Stop One of the Deadliest Forms of Breast Cancer Before It StartsJuly 11, 2025 | msn.comBreakthrough breast cancer vaccine raises hopes of eradicating diseaseJuly 11, 2025 | au.news.yahoo.comAnixa Biosciences Announces Issuance of Additional U.S. Patent for ...July 11, 2025 | morningstar.comMIs Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This ...July 11, 2025 | nasdaq.comAnixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine TechnologyJuly 9, 2025 | prnewswire.comBreast cancer vaccine breakthrough as more than 75% of women show immune response in new testJuly 8, 2025 | ca.news.yahoo.comAnixa Biosciences (NASDAQ:ANIX) Trading Down 0.6% - Here's WhyJuly 8, 2025 | marketbeat.comANIX - Anixa Biosciences Inc Dividends - MorningstarJune 24, 2025 | morningstar.comMAnixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical TrialJune 23, 2025 | prnewswire.comPreventing Cancer Before It Starts: New Vaccine Could Revolutionize The Fight Against Breast CancerJune 21, 2025 | msn.comAnixa Biosciences to Host an Investor Webcast on June 26, 2025June 20, 2025 | prnewswire.comBreast cancer vaccine shows promising results in phase 1 clinical trialsJune 19, 2025 | msn.comBreast cancer vaccine showing progressJune 17, 2025 | msn.comAnixa Biosciences (NASDAQ:ANIX) Receives Buy Rating from D. Boral CapitalJune 10, 2025 | marketbeat.comAnixa Biosciences' Breast Cancer Vaccine Receives National News CoverageJune 10, 2025 | prnewswire.comBreakthrough vaccine could eradicate breast cancer, shows 75% immune response in trialJune 9, 2025 | msn.comAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025June 9, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street ZenJune 6, 2025 | marketbeat.comAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO Amit Kumar Acquires 10,000 SharesJune 6, 2025 | insidertrades.comH.C. Wainwright maintains Buy rating on Anixa Biosciences stockJune 6, 2025 | uk.investing.comAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO Buys $28,500.00 in StockJune 5, 2025 | marketbeat.comHC Wainwright Lifts Earnings Estimates for Anixa BiosciencesJune 5, 2025 | marketbeat.comAnixa Biosciences' Breast Cancer Vaccine Featured in NewsNation InterviewJune 3, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Announces Quarterly Earnings ResultsJune 3, 2025 | marketbeat.comAnixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer VaccineJune 2, 2025 | prnewswire.com Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANIX Media Mentions By Week ANIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIX News Sentiment▼0.281.03▲Average Medical News Sentiment ANIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIX Articles This Week▼23▲ANIX Articles Average Week Get the Latest News and Ratings for ANIX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Rocket Pharmaceuticals News Y-mAbs Therapeutics News Vigil Neuroscience News Astria Therapeutics News Fulcrum Therapeutics News Abeona Therapeutics News Inhibrx Biosciences News ADC Therapeutics News CytomX Therapeutics News Aldeyra Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Anixa Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access